Catabasis names Rick Modi chief business officer
This article was originally published in Scrip
Executive Summary
Catabasis Pharmaceuticals, a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of therapeutics using its SMART linker technology platform, has named Rick Modi chief business officer. Prior to joining Catabasis, Mr Modi was senior vice-president, global marketing at InterMune, an orphan drug company that was acquired by Roche in 2014.